Molecular Partners AG
SIX:MOLN
Molecular Partners AG
SIX:MOLN
Price:
3.61
CHF
0.84%
Market Closed
Market Cap:
CHf145.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Molecular Partners AG
SIX:MOLN
|
CH |
|
D
|
Direcional Engenharia SA
BOVESPA:DIRR3
|
BR |
|
Hyosung TNC Corp
KRX:298020
|
KR |
|
Rank Group PLC
LSE:RNK
|
UK |
|
Sparebanken Sor
OSE:SOR
|
NO |
|
NI Holdings Inc
NASDAQ:NODK
|
US |
|
I
|
Informasi Teknologi Indonesia Tbk PT
IDX:JATI
|
ID |
|
C
|
China Changjiang Mining & New Energy Co Ltd
OTC:CHJI
|
CN |
|
Zhongtai Futures Co Ltd
HKEX:1461
|
CN |
|
Rajdarshan Industries Ltd
NSE:ARENTERP
|
IN |
|
China Railway Group Ltd
SSE:601390
|
CN |
|
I
|
Irwin Naturals Inc
CNSX:IWIN
|
US |
Balance Sheet
Balance Sheet Decomposition
Molecular Partners AG
Molecular Partners AG
Balance Sheet Decomposition is not available for
Molecular Partners AG
Molecular Partners AG
Balance Sheet
Molecular Partners AG
Molecular Partners AG
Currency: CHF
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
96
|
188
|
195
|
150
|
131
|
99
|
76
|
134
|
72
|
88
|
67
|
64
|
83
|
|
| Cash |
0
|
0
|
0
|
150
|
131
|
99
|
76
|
134
|
72
|
88
|
67
|
64
|
83
|
|
| Cash Equivalents |
96
|
188
|
195
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
20
|
30
|
10
|
0
|
19
|
40
|
61
|
161
|
120
|
86
|
10
|
|
| Total Receivables |
12
|
3
|
1
|
1
|
1
|
52
|
3
|
3
|
26
|
2
|
3
|
3
|
2
|
|
| Accounts Receivables |
11
|
3
|
1
|
0
|
0
|
49
|
0
|
0
|
24
|
1
|
1
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
2
|
0
|
2
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
1
|
6
|
4
|
2
|
2
|
2
|
|
| Total Current Assets |
108
|
192
|
217
|
182
|
143
|
153
|
100
|
178
|
164
|
255
|
192
|
154
|
97
|
|
| PP&E Net |
2
|
2
|
3
|
2
|
2
|
1
|
4
|
9
|
8
|
7
|
6
|
4
|
5
|
|
| PP&E Gross |
2
|
2
|
3
|
2
|
2
|
1
|
4
|
9
|
8
|
7
|
6
|
4
|
5
|
|
| Accumulated Depreciation |
3
|
3
|
4
|
5
|
6
|
7
|
9
|
11
|
13
|
15
|
16
|
18
|
20
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
110
N/A
|
194
+76%
|
219
+13%
|
184
-16%
|
144
-22%
|
155
+7%
|
105
-32%
|
188
+79%
|
173
-8%
|
262
+52%
|
198
-24%
|
159
-20%
|
102
-36%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
1
|
2
|
2
|
3
|
5
|
1
|
0
|
1
|
1
|
|
| Accrued Liabilities |
4
|
3
|
3
|
4
|
5
|
7
|
7
|
11
|
13
|
9
|
8
|
9
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Liabilities |
19
|
19
|
22
|
10
|
9
|
28
|
18
|
43
|
28
|
6
|
4
|
0
|
0
|
|
| Total Current Liabilities |
23
|
22
|
26
|
16
|
14
|
37
|
29
|
58
|
47
|
17
|
14
|
11
|
11
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
5
|
4
|
2
|
1
|
2
|
|
| Other Liabilities |
39
|
23
|
41
|
33
|
14
|
27
|
21
|
17
|
14
|
6
|
5
|
5
|
8
|
|
| Total Liabilities |
62
N/A
|
46
-26%
|
68
+49%
|
48
-29%
|
28
-43%
|
63
+129%
|
51
-20%
|
80
+58%
|
65
-19%
|
27
-59%
|
22
-19%
|
17
-23%
|
22
+29%
|
|
| Equity | ||||||||||||||
| Common Stock |
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
4
|
4
|
4
|
4
|
|
| Retained Earnings |
14
|
17
|
18
|
37
|
61
|
90
|
131
|
195
|
251
|
128
|
192
|
246
|
312
|
|
| Additional Paid In Capital |
67
|
167
|
169
|
171
|
175
|
179
|
183
|
299
|
355
|
360
|
366
|
385
|
389
|
|
| Treasury Stock |
6
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
| Total Equity |
48
N/A
|
149
+207%
|
152
+2%
|
136
-11%
|
117
-14%
|
92
-21%
|
54
-41%
|
107
+98%
|
107
+0%
|
235
+119%
|
176
-25%
|
142
-20%
|
80
-43%
|
|
| Total Liabilities & Equity |
110
N/A
|
194
+76%
|
219
+13%
|
184
-16%
|
144
-22%
|
155
+7%
|
105
-32%
|
188
+79%
|
173
-8%
|
262
+52%
|
198
-24%
|
159
-20%
|
102
-36%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
19
|
20
|
20
|
21
|
21
|
21
|
22
|
29
|
32
|
33
|
33
|
37
|
37
|
|
Switch to:
Switch to:
See Also
Discover More
